AI
ADAP

Acuitas Investments’s Adaptimmune Therapeutics ADAP Stock Holding History

Acuitas Investments’s Portfolio ADAP Stock Details ADAP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-541,201
Closed -$528K – 118
2024
Q2 		$528K Buy
541,201
+2,880
+0.5% +$2.81K 0.28% 96
2024
Q1 		$851K Buy
538,321
+58,532
+12% +$92.5K 0.43% 73
2023
Q4 		$380K Buy
479,789
+25
+0% +$20 0.2% 106
2023
Q3 		$374K Buy
+479,764
New +$374K 0.22% 95